Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

Nov 6, 2013

30339_dirs_2013-11-06_b4c1196b-40c6-49f3-8865-78ca24f4851b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-11-04

Reporting Person: Hunt Jeffrey C (VP Pharma Pckg Systems)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-04 Common Stock M 7883.0000 $21.2200 Acquired 23176.9264 Direct
2013-11-04 Common Stock F 3558.0000 $47.0100 Disposed 19618.9264 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-11-04 Stock Option (Right to Buy) $21.2200 M 7883.0000 Disposed 2022-02-21 Common Stock (7883.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 652.4648 Indirect
Common Stock 15172.1632 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.